Old Web
English
Sign In
Acemap
>
Paper
>
PO-0753: Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC
PO-0753: Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC
2018
Kate Haslett
Fiona Blackhall
P. Koh
Linda Ashcroft
Marie-Claude Asselin
Catherine Harris
A. Jackson
Prakash Manoharan
Damien Mullan
W David J Ryder
Benjamin Taylor
Corinne Faivre-Finn
Keywords:
Radiology
Selumetinib
MEK inhibitor
Radiation therapy
Medicine
Concomitant
Oncology
Internal medicine
thoracic radiotherapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]